Evaluation of sonographic detectability of different markers within an in vitro simulation model of the axilla

Arch Gynecol Obstet. 2021 Sep;304(3):839-848. doi: 10.1007/s00404-021-06085-9. Epub 2021 Jun 17.

Abstract

Purpose: Clip-marking of axillary lymph nodes with initial biopsy-confirmed metastasis is required for targeted axillary dissection (TAD), which includes sentinel lymph node dissection (SLND) and selective localization and removal of the clipped targeted lymph node. There have been several studies which examined the feasibility of TAD in routine clinical use. In this context, the optimal clip visualisation was noted as one of the crucial limiting factors. We, therefore, evaluated the sonographic detectability of 10 different commercially available markers within an in vitro model simulating the anatomical composition of the axilla.

Methods: In this standardised model consisting of porcine fat with 30 mm thickness, the visibility of a total of ten markers was analysed in all 3 planes (parallel, diagonal, orthograde) with wire guidance and then classified into either "visibility good", "visibility moderate" or "visibility poor" with regard to the alignment of the transducer. Additionally, "real-life conditions" were simulated, in which the markers were searched without any wires guidance.

Results: It was observed that, while not all markers are detectable in fatty tissue, markers with spherical shape (non-embedded Inconel or Nitinol) or rectangular-shaped Titanium markers with embedded material have a clear advantage. 3D-shaped markers can always be detected in all three axes, which is of particular importance in the axilla with its pyramid shape and fatty tissue.

Conclusion: The shape and the embedding of the material play a crucial role for visibility and efficacy of the marker, as reliable marking of suspicious and pathological axillary lymph nodes is essential for TAD.

Keywords: Breast cancer; Clip-marking; Lymph node; Sonographic detectability; Targeted axillary dissection.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Axilla
  • Breast Neoplasms / diagnostic imaging
  • Female
  • Humans
  • Lymph Node Excision / methods*
  • Lymph Nodes / diagnostic imaging*
  • Lymphatic Metastasis / diagnosis*
  • Lymphatic Metastasis / therapy
  • Mastectomy / instrumentation
  • Mastectomy / methods*
  • Neoplasm Staging
  • Sentinel Lymph Node Biopsy / methods
  • Sentinel Lymph Node* / diagnostic imaging
  • Sentinel Lymph Node* / pathology
  • Sentinel Lymph Node* / surgery